"The stellar academic record of Dr. Min and his continual involvement should not only help accelerate our therapeutics development process, but should also position us for numerous grant and philanthropic funding to support the ongoing translational development."
I just noticed this on their LOI PR for RNA gene silencing to treat cancer. It looks like they bought the patent to target grant funding. This could be good for BMSN if they can find grant funding to help them through clinical trials.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.